On June 17th, 2019, Professor Yanchao Qi, a well-known Chinese cancer biotherapy expert, visited the Sino-British Science and Technology Innovation Platform. Chairman Ren Xiang and Deputy Secretary-General Enron warmly received the platform and held cooperation talks with it on cell biotechnology.
Professor Yanchao Qi, who graduated from the Medical Department of Henan Medical University, is a national expert with special contributions, enjoys special government allowance, and has been engaged in the research on clinical application of tumors and tumor biotherapy for more than 30 years. He has made great contributions to the treatment of tumors in China, especially for the research and clinical application of biotechnology in treating tumors. The core patented technology he presided over-healthy human immune cells, is the most advanced biological immune technology in the world.
At the symposium, Professor Yanchao Qi said that the Sino-British biomedical innovation sharing accelerator project of Sino-British science and technology innovation platform landed in Zhengdong New District has broad prospects, benefits the country and the people, and can not only benefit the lives and health of people in Henan and even the whole country, but also promote the innovation pace of cell biotechnology in China and even the world. As a medical worker, he himself is very willing to make some contributions to his hometown and the whole country, and he is very grateful to the Sino-British scientific and technological innovation platform for creating such an opportunity for him.
President Ren Xiang was honored to invite Professor Yanchao Qi, a life science expert, to visit the platform. As a key project of Henan Province in 2019, the Sino-British Biomedical Innovation Sharing Accelerator Project will certainly live up to the expectations of the government leaders and the people of the whole province, innovate scientific research, overcome difficulties and make due contributions in the field of life and health. At the same time, Mr. Ren also said that cell biotechnology is still a new topic in the current field of life and health, and it especially needs the guidance of experienced and skilled industry experts. Sino-British Science and Technology Innovation Platform is full of expectations for cooperation with Professor Yanchao Qi.
Subsequently, the two sides had a heated discussion on the current development of cell biotechnology and the medical industry, especially on tumor biotherapy. This negotiation has pointed out the direction for the upcoming cooperation between the two sides.
.png)
